Clinical Research Directory
Browse clinical research sites, groups, and studies.
The GUARDIAN Trial - Vasopressor Sub-Study
Sponsor: The University of Texas Health Science Center, Houston
Summary
This is a sub-study of the overall GUARDIAN trial (NCT04884802) in which some GUARDIAN trial participants will be additionally randomized to norepinephrine or phenylephrine infusion to maintain the designated target intraoperative mean arterial pressure.
Official title: Tight Perioperative Blood Pressure Management to Reduce Serious Cardiovascular, Renal, and Cognitive Complications: The GUARDIAN Trial (Vasopressor Sub-study Comparing Phenylephrine and Norepinephrine)
Key Details
Gender
All
Age Range
45 Years - Any
Study Type
INTERVENTIONAL
Enrollment
6254
Start Date
2021-07-25
Completion Date
2027-04-25
Last Updated
2025-08-29
Healthy Volunteers
No
Conditions
Interventions
Routine Blood Pressure Management
Routine blood pressure control.
Tight Blood Pressure Management
Tight blood pressure control.
Phenylephrine
Phenylephrine will be infused at a rate sufficient to maintain the intraoperative MAP designated in the underlying GUARDIAN trial.
Norepinephrine
Norepinephrine will be infused at a rate sufficient to maintain the intraoperative MAP designated in the underlying GUARDIAN trial.
Locations (11)
University of Nebraska Medical Center
Omaha, Nebraska, United States
MetroHealth Medical Center
Cleveland, Ohio, United States
Cleveland Clinic Fairview Hospital
Cleveland, Ohio, United States
Cleveland Clinic Main Campus
Cleveland, Ohio, United States
Beijing Shijitan Hospital, Capital Medical University
Beijing, China
Peking Union Medical College Hospital
Beijing, China
Shanghai Ninth People's Hospital
Shanghai, China
Shanghai Chest Hospital
Shanghai, China
West China Hospital
Sichuan, China
University of Thessaly
Larissa, Greece
National Defense College
Tokyo, Japan